Form NPORT-P T. Rowe Price Retirement For: Nov 30
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPM Interim Report Q1 2024: A positive start to the year, growth investments contributed to earnings
- Tim Kirchen appointed Executive Vice President, UPM Raflatac and member of the Group Executive Team
- Hemogenyx Pharmaceuticals PLC Announces Final Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!